Related references
Note: Only part of the references are listed.Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse
Christina Gianoulakis
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?
G. Linazasoro et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Opioidergic and dopaminergic modulation of respiration
Peter M. Lalley
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2008)
δ-, but not μ-, opioid recegtor stabilizes K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia
Dongman Chao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors
Stephan Loacker et al.
BRAIN (2007)
Systemic naloxone infusion may trigger spasticity in patients with spinal cord injury: Case series
Nancy L. Brackett et al.
JOURNAL OF SPINAL CORD MEDICINE (2007)
Elimination diets in autism spectrum disorders: Any wheat amidst the chaff?
George W. Christison et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2006)
Endogenous opiates and behavior: 2004
RJ Bodnar et al.
PEPTIDES (2005)
Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis
L Kennedy et al.
BRAIN RESEARCH (2005)
Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors
MM Nieto et al.
NEUROSCIENCE (2005)
Neuronal types expressing μ- and δ-opioid receptor mRNA in the rat hippocampal formation
RK Stumm et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: Linking hibernation and neuroprotection
CV Borlongan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner
S Takabuchi et al.
FEBS LETTERS (2004)
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia
P Ravenscroft et al.
EXPERIMENTAL NEUROLOGY (2004)
Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention
B Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Neuroprotective role of δ-opioid receptors in cortical neurons
JH Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands
AJ Wakefield et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane
T Itoh et al.
FEBS LETTERS (2001)
μ- and δ-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
B Henry et al.
EXPERIMENTAL NEUROLOGY (2001)
μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients
AM Mathieu-Kia et al.
BRAIN RESEARCH (2001)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
Share Paper
